There are some 2,000 cases (80% fatal) of Acute Liver Failure (ALF) in the US each year. Scientists at Israel’s Weizmann Institute have managed to control the severity of ALF in the lab by blocking signals from the gut microbiome to the MYC protein in the liver.
Prospective treatment for liver failure
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.